EUVIMEDEUVIMED entdecken
Crossref

In-silico identification of microbial bile salt hydrolase inhibitors for modulating bile acid driven signalling in hepatocellular carcinoma

Manikandan Moorthy, Jitesh Mahadeva Prabhu, Harani Thirupathi, Harish Ram Sanjeevimoorthy, Eswara Rajagopal, Balaji Sadhasivam

BIOCHEMICAL AND CELLULAR ARCHIVES · 27.02.2026 · 26 (1) · 697-706

DOI: 10.51470/bca.2026.26.1.697 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BIOCHEMICAL AND CELLULAR ARCHIVES, online erschienen am 05.03.2026. Verfasst von Manikandan Moorthy und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microbial bile salt hydrolase (BSH) is a metabolically therapeutic target in hepatocellular carcinoma (HCC), which has been targeted through an in-silico approach. The crystal structure of BSH from Clostridium perfringens (PDB ID: 2BJF) was analysed to define its conserved catalytic pocket, followed by molecular docking of twelve natural bioactive compounds and reference inhibitors. Docking analysis revealed strong binding affinities for ursodeoxycholic acid (–9.6 kcal·mol-1), AAA-10 (–9.1 kcal·mol-1) and taraxerol acetate (–9.0 kcal·mol-1), with stable occupancy within the Arg18–Cys2 centered active site. Protein–protein interaction analysis using STRING positioned BSH within lipid and bile acid metabolic networks, indicating coordinated metabolic functionality rather than isolated enzymatic action. ADMET and toxicity profiling showed broad compliance with Lipinski criteria and low predicted cardiotoxicity, while differentiating candidates based on hepatotoxicity and genotoxicity risks. Thereby, the study validates BSH inhibition as a viable microbiome-centered strategy to modulate bile acid–driven oncogenic signalling in HCC.

Zitieren

APA

Moorthy, M., Prabhu, J. M., Thirupathi, H., Sanjeevimoorthy, H. R., Rajagopal, E., & Sadhasivam, B. (2026). In-silico identification of microbial bile salt hydrolase inhibitors for modulating bile acid driven signalling in hepatocellular carcinoma. BIOCHEMICAL AND CELLULAR ARCHIVES, 26(1), 697-706. https://doi.org/10.51470/bca.2026.26.1.697

Vancouver

Moorthy M, Prabhu JM, Thirupathi H, Sanjeevimoorthy HR, Rajagopal E, Sadhasivam B. In-silico identification of microbial bile salt hydrolase inhibitors for modulating bile acid driven signalling in hepatocellular carcinoma. BIOCHEMICAL AND CELLULAR ARCHIVES. 2026;26(1):697-706. doi:10.51470/bca.2026.26.1.697

BibTeX
@article{Moorthy2026,
  author = {Moorthy, Manikandan and Prabhu, Jitesh Mahadeva and Thirupathi, Harani and Sanjeevimoorthy, Harish Ram and Rajagopal, Eswara and Sadhasivam, Balaji},
  title = {In-silico identification of microbial bile salt hydrolase inhibitors for modulating bile acid driven signalling in hepatocellular carcinoma},
  journal = {BIOCHEMICAL AND CELLULAR ARCHIVES},
  year = {2026},
  volume = {26},
  number = {1},
  pages = {697--706},
  doi = {10.51470/bca.2026.26.1.697}
}
Kostenlos starten →